Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-11-26
2010-06-08
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S556000
Reexamination Certificate
active
07732481
ABSTRACT:
Novel compounds of the formula (I), in which R, R1, R2, R3, X, X′ and Y have the meaning indicated in Patent Claim1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
REFERENCES:
patent: 2003/0162787 (2003-08-01), Bigge
patent: 2007/0135507 (2007-06-01), Mederski et al.
patent: WO 03045912 (2003-06-01), None
patent: WO 2004087646 (2004-10-01), None
patent: WO 2004087696 (2004-10-01), None
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Tsaklakidis Christos
Merck Patent Gesellschaft mit beschrankter Haftung
Millen White Zelano & Branigan P.C.
Saeed Kamal A
LandOfFree
Prolinylarylacetamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolinylarylacetamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolinylarylacetamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244630